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A B S T R A C T
Anemia is common in patients with chronic kidney disease (CKD) and contributes to cardiovascular alterations. Re-
cent findings suggest that B-type natriuretic peptide (BNP) is a sensitive biomarker for left ventricular dysfunction, but
relationship between hemoglobin and BNP in CKD patients is unclear. Hemoglobin, plasma BNP and serum creatinine
levels were measured in 49 patients with CKD (without heart failure), divided in two groups according to the hemoglobin
status (cut-off point 110 g/L). All patients underwent echocardiography in order to assess left ventricular (LV) morphol-
ogy and function. The results showed that in the group of patients with hemoglobin levels under 110 g/L BNP levels were
significantly elevated (p<0.001), as well as left ventricular mass index (p<0.001). Systolic and diastolic LV function
were significantly better in patients with hemoglobin levels above 110 g/L (p<0.001). Hemoglobin levels were inversely
related to BNP values (r=–0.451, p<0.001). Significantly negative correlation between BNP level and creatinine clear-
ance (p=0.009), and significantly positive correlation between BNP level and left ventricular mass index (LVMI) were es-
tablished. A similar but positive relationship was observed between hemoglobin levels and creatinine clearance (p<0.01).
We established statistically significant negative correlation between hemoglobin levels and LVMI (r=–0.564, p<0.001).
In conclusion, BNP and hemoglobin levels depend on the renal function. Anemia may contribute to elevated BNP levels
in CKD patients, and may represent an important confounder of the relationship between BNP and cardiac alteration in
these patients.
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Introduction
Cardiovascular diseases are the leading cause of mor-
bidity and mortality in patients with chronic kidney
disease1. Left ventricular hypertrophy (LVH) is frequen-
tly observed cardiac alteration in these patients2. Patho-
genesis of LVH in patients with chronic kidney disease is
multifactorial and includes systolic hypertension, ane-
mia, older age life, etc. Anemia is a basic characteristic of
chronic kidney disease, and pathogenetically besides
other factors includes the deficit of erythropoietin, ab-
breviated life of erythrocytes, the deficit of nutritional
factors and disturbance of iron metabolism. In a state of
relative tissue hypoxia, anemia causes peripheral vasodi-
latation as a compensatory response, and the peripheral
vasodilatation and decrease of the blood viscosity result-
ing in an increased vein inflow as well as an increase in
cardiac output. Cardiac output increases to meet meta-
bolic needs and leads to the remodeling of left ventricle3.
Studies so far have indicated that B-type natriuretic pep-
tide (BNP) is a sensitive biomarker of left ventricular
hypertrophy4,5, and that anemia can have a significant
impact on the concentration of B-type natriuretic pep-
tide (BNP) in the plasma6.
141
Received for publication March 13, 2009
The aim of this study was to determine the relation-
ship between the concentration of hemoglobin in the
blood and the concentration of BNP in plasma, and their




The study included 49 patients (19 men and 30 wo-
men) with chronic kidney disease (creatinine clearance
<60 mL/min), without the need for renal replacement
therapy. All patients were divided into two groups based
on their hemoglobin status: the group with hemoglobin
concentration lower than 110 g/L and the group with he-
moglobin concentration higher than 110 g/L. The study
was conducted at the Clinic of Nephrology, University
Clinical Center in Sarajevo, during the period from Sep-
tember 2006 to December 2008. The study did not in-
clude patients with coronary heart disease, congenital
heart malformations or heart failure.
Methods
Echocardiograph examination was carried out using
ultrasonic recorder Toshiba SSH 140 with 2.5 MHz trans-
ducer and the cardiologist who was not familiar with the
clinical patient data. Measurements of left ventricular
posterior wall thickness (PWd), interventricular septal
wall thickness (IVSd) and left ventricular internal diam-
eter (LVIED) were made from long-axis parasternal posi-
tion at the end of diastole. Left ventricular (LV) mass was
calculated according to Devereux modified formula of the
American Society of Echocardiography, and LV mass in-
dex was derived by dividing LV mass to body surface
area. LVH was defined as the left ventricular mass index
(LVMI) >131 g/m2 for men and >100 g/m2 for women in
accordance with Framingham criteria7. Echocardiogra-
phic measurements in all patients were performed on the
day when the blood sample was taken to measure the
level of BNP.
Level of plasma B-type natriuretic peptide was mea-
sured by the technique of enzymatic immunoassay using
commercial kit assays AxSYM BNP on appliance AxSYM
Abbott. Levels of BNP up to 100 pg/mL were considered
as normal values. Concentration of hemoglobin in the
blood and serum concentration of creatinine were deter-
mined by the routine laboratory methods. All measure-
ments were performed at the Institute for Clinical Bio-
chemistry at the University Clinical Center Sarajevo, the
same day when the blood sample was taken. The level of
creatinine clearance (mL/min) was calculated by using
the Cockroft-Gault formula: (140-age) ´ body weight (kg)
/0.81 ´ serum creatinine (ìmol/L), whose result for female
persons is multiplied with the constant 0.85.
Statistics
Statistical analysis was performed using SPSS soft-
ware (version 16). Data were expressed as means and
standard deviation (SD) for normally distributed variab-
les and as median with interquartile ranges for non-nor-
mally distributed data. Comparations between groups
were made by Student’s t-test and Mann-Whitney U test,
for normally and non-normally distributed date. Coeffi-
cient of correlation was assessed by Spearman. We as-
sumed a statistical significance for p<0.05.
Results
From a total of 49 observed patients with chronic kid-
ney disease, 26 patients had blood level of hemoglobin be-
low 110 g/L (average value 91.5 g/L) and 23 patients
above 110 g/L (128.8 g/L). Demographic, laboratory and
echocardiographic characteristics of patients per group
are shown in Table 1. Between the tested groups there
were no significant differences in age.
Average value of B-type natriuretic peptide concen-
tration in the group of patients with severe renal anemia
(Hgb<110 g/L) was significantly higher compared to the
group of patients with a hemoglobin level above 110 g/L
(median 922.6 pg/mL vs. 103.4 pg/mL, p<0.001, Figure
1). Value of creatinine clearance, expressed in mL/min,
was significantly lower in the group of patients with a
greater degree of renal anemia (33.8 mL/min vs. 62.7
mL/min, p<0.001).
Echocardiographic analysis indicates that LV mass in-
dex is significantly higher in renal patients with more pro-
nounced anemia and lower creatinine clearance (p<0.001).
Patients with hemoglobin levels higher than 110 g/L
have a significantly better systolic (EF 57.2% vs. 54.2%,
p<0.001) and diastolic LV function (E/A 0.90 vs. 0.75,
p<0.001).
The inverse relationship of BNP concentration and
the hemoglobin level of statistical significance in ob-
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TABLE 1









Age (years) 52.2±3.5 55.6±2.3









IMLV (g/m2) 185.4±8.05 141.4±8.3*
EF (%) 54.2±2.3 57.2±1.2*
E/A 0.75±0.03 0.90±0.05*
Results are presented as mean ± standard deviation or as me-
dian with interquartile range
* p<0.05 in comparation with group 1(patients with hemoglobin
status <110 g/L)
served patients with chronic kidney disease was showed
(r=–0.451, p<0.001, Figure 2).
Significant negative relationship between level of he-
moglobin and LV mass index, as well as significant posi-
tive relationship between level of BNP and LV mass in-
dex were demonstrated (Table 2).
At the same time creatinine clearance, as an indicator
of endogenous renal function, shows a significant posi-
tive correlation with the hemoglobin value, and the in-
verse correlation with the BNP concentration. The level
of BNP in plasma is shown as a negative indicator of sys-
tolic and diastolic LV function, while the hemoglobin is in
positive correlation with ejection fraction of LV and with
the parameter of diastolic LV function, E/A.
Discussion
Anemia associated with chronic kidney disease is de-
fined with low hemoglobin values and accompanied with
significant cardiovascular morbidity. Mechanisms of car-
diovascular adjustment to anemia are reflected in the in-
creasing cardiac output, initiated by the decrease of vas-
cular peripheral resistance and increase of the heart rate
and left ventricular contractility due to increase in con-
centration of catecholamines and non-catecholamines
inotropic factors and chemoreceptor stimulation by hy-
poxia and increase in sympathetic nerve activity3,8.
The results of our study clearly confirm the relation-
ship between the degree of anemia and degree of kidney
dysfunction, and the size of LV mass index. Patients with
hemoglobin levels below 110 g/L have a significantly
greater LV mass index and significantly poorer systolic
and diastolic LV function.
At the same time it has been confirmed that renal pa-
tients with lower hemoglobin values have significantly
higher values of BNP concentration. Identified signifi-
cant negative correlation between hemoglobin status and
BNP concentration in monitored patients, as well as be-
tween the level of creatinine clearance and BNP concen-
tration, indicates that higher BNP concentrations, as
anemia, may be the result of renal impairment.
This study has also confirmed significantly higher
BNP concentrations in patients with more pronounced
LV hypertrophy, and significant positive correlation of
BNP levels with the LV mass index. This observation
may reflect increased production of BNP in association
with left ventricular hypertrophy. BNP is a polypeptide
which is being synthesized as a preproBNP in the ventri-
cular myocardium and enzymatically cleaved into proBNP.
Prohormone (proBNP) is under the action of enzymes
from the group of proteases cleaved to the biologically ac-
tive form of BNP and amino terminal portion of pro-
hormone – NTproBNP. Active hormone BNP is being ex-
creted in ventricles in response to myocite stretching and
is therefore believed to be a more sensitive indicator of
the ventricular structure from other natriuretic peptides.
Vasodilatation and hemodynamic alteration in renal
anemia contribute to an increase in venous blood return
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Fig. 1. Plasma BNP concentration in CKD patients by hemoglo-
bin status. Bars indicate maximum and minimum value, while
the square and its central bar are showing the intequartile range
and median.
















Fig. 2. Relationship between BNP and hemoglobin concentrations
in CKD patients.
TABLE 2
CORRELATION BETWEEN HEMOGLOBIN AND BNP STATUS






















to the heart and the gradual development of LVH. Left
ventricular hypertrophy is eccentric, characterized by in-
crease of LV internal diameter and normal attitude of the
wall thickness toward diameter of the cavity, as it occurs
in other forms of load volume. It is known that LV mass
increases with kidney disease progression9. Expansion of
the ventricular wall in response to volume expansion and
increase of pressure in the ventricle, together with neuro-
humoral stimulation, induces BNP secretion. Signifi-
cantly higher values of BNP in renal patients with grea-
ter LV mass index, and significantly positive correlation
between BNP levels and LV mass index, as well as signifi-
cantly negative correlation of BNP values with diastolic
function of hypertrophic myocardium indicates that the
BNP is a sensitive indicator of ventricular structure and
function.
Significantly higher levels of BNP in the presence of
the higher level of kidney failure could be the result of
combining renal failure and the presence of cardiac dis-
ease, respectively LV hypertrophy. Mark et al.10 showed
that the level of BNP depends on renal and cardiac dys-
function, as well as numerous factors associated with the
progression of kidney diseases, including the anemia and
LVH. Study by Knudsen et al.6 suggests that anemia may
contribute to the increase of BNP level in the absence of
heart failure, and that anemia contributes significantly
to the relation between BNP concentrations and cardiac
function, as well as prognosis.
In conclusion, results of our study indicate that the
levels of hemoglobin and the levels of BNP depend on
renal function, but also there is causal relation between
anemia, levels of BNP and cardiac alterations, such as
LV hypertrophy in chronic kidney disease. Anemia may
contribute to elevated BNP levels in CKD patients, and
may represent an important confounder of the relation-
ship between BNP and cardiac alteration in these pa-
tients.
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UTJECAJ KONCENTRACIJE HEMOGLOBINA NA RAZINU NATRIURETSKOG PEPTIDA TIPA B
I EHOKARDIOGRAFSKE KARAKTERISTIKE LIJEVE SR^ANE KLIJETKE U BOLESNIKA SA
KRONI^NOM BUBRE@NOM BOLESTI
S A @ E T A K
Anemija je ~esto prisutna u bolesnika sa kroni~nom bubre`nom bolesti (KBB) i doprinosi pojavi kardiovaskularnih
promjena. Noviji nalazi sugeriraju da je natriuretski peptid tipa B (BNP) senzitivan biomarker disfunkcije lijeve sr~ane
klijetke, ali je odnos izme|u hemoglobina i BNP-a u bolesnika sa KBB jo{ nejasan. Razine hemoglobina, plazmatskog
BNP-a i serumskog kreatinina su mjerene u 49 bolesnika sa KBB (kreatinin klirens <60 mL/min), razdijeljene u dvije
grupe prema statusu hemoglobina (to~ka razdvajanja 110 g/L). Svim pacijentima je ura|ena ehokardiografija u cilju
utvr|ivanja morfologije i funkcije lijeve sr~ane klijetke (LK). Rezultati pokazuju da su u grupi bolesnika sa razinom
hemoglobina iznad 110 g/L, razine BNP-a bile signifikantno pove}ane (p<0,001), kao i indeks mase lijeve klijetke
(p<0,001). Sistolna i dijastolna funkcija LK su bile signifikantno bolje u bolesnika sa razinom hemoglobina iznad 110
g/L (p<0,001). Razine hemoglobina su u inverznom odnosu sa razinom BNP-a (r=–0,451, p<0,001). Utvr|ena je signi-
fikantna negativna korelacija izme|u razine BNP-a i kreatinin klirensa (p=0,009), te signifikantna pozitivna korelacija
izme|u razine BNP-a i indeksa mase lijeve klijetke (IMLK). Sli~an, ali pozitivan odnos je uo~en izme|u razina hemoglo-
bina i kreatinin klirensa (p<0,01). Utvrdili smo statisti~ki signifikantnu negativnu korelaciju izme|u razina hemoglo-
bina i IMLK (r =–0,564, p<0,001). U zaklju~ku, razine BNP-a i hemoglobina su ovisne od bubre`ne funkcije. Anemija
mo`e doprinositi pove}anju razina BNP-a u bolesnika sa KBB, te mo`e predstavljati zna~ajan ~imbenik odnosa izme|u
BNP-a i sr~anih promjena u ovih bolesnika.
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